NVAX NOVAVAX INC Earnings Reports 8-K Filing 2024 - Results of Operations and Financial Condition Novavax, Inc. provided an update for investors reaffirming its guidance for full year 2023 expenses, which is anticipated to be between $1.15 billion and $1.25 billion.Get access to all SEC 8-K filings of the NOVAVAX INC